MarketInOut Stock Screener Log In | Sign Up
 

Bayer AG

XETRA • Healthcare • Drug Manufacturers - General • Quote as of 05/04/2026 17:35
Bayer AG stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeXETRA
Market Capitalization37,381 mln
Float982 mln
Earnings Date05/12/2026

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.84
Likely reliable

1-Year Forecast

48.47
Strong upside

Relative Strength

7 / 100
Severely lagging

Debt / Equity

1.40
Elevated leverage

Pre-Tax Margin

13.47%
Moderate margin

Business Description

Founded in 1863 and headquartered in Leverkusen, Germany, Bayer is a global life sciences company serving customers across Europe, North America, Asia Pacific, Latin America, and beyond. Its healthcare business spans prescription medicines for heart conditions, women's health, cancer, and eye disease, alongside everyday over-the-counter products such as pain relievers, allergy treatments, and nutritional supplements. Through its agriculture division, Bayer supplies farmers with crop protection products, seeds, and digital tools designed to improve yields and manage pests and weeds. The company sells through pharmacies, supermarkets, hospitals, and online retailers, as well as directly to those working in farming.

Key Fundamentals

EPS-3.68
ROE-12.05
RPS46.39
ROIC6.46
ROA-3.39
Interest Cover2.99
EBITDA, mln1,706
EV / EBITDA38.93
EV / EBIT-61.55
Revenue, mln45,575
EV / Revenue1.46

Financial Strength

Altman Z-Score0.69
Piotroski F-Score 6 / 9
Beneish M-Score-2.84
Price to Intrinsic Value0.69
1-Year Target Price48.47
Shiller PE Ratio45.16

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.58% 12 / 100   
1 Month -4.76% 7 / 100   
2 Months -15.82% 10 / 100   
6 Months 36.65% 94 / 100   
1 Year 54.99% 92 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us